Join
Live feed
·
PRReleasevia Quantisnow
Oyster Point Pharma Inc. logo
Viatris Inc. logo

Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OYST (Oyster Point Pharma Inc.), VTRS (Viatris Inc.) and more on Quantisnow.